Compare Abbott Laboratories (ABT) vs Trump Media and Technology Group Corp (DJT) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abbott Laboratories vs Trump Media and Technology Group Corp — how do they compare? Abbott Laboratories trades at $95.43 (market cap $166.94B), while Trump Media and Technology Group Corp trades at $8.18 (market cap $2.25B). The key difference: Abbott Laboratories is far larger — about 74.2× Trump Media and Technology Group Corp's market cap, and Abbott Laboratories pays a 2.63% dividend while Trump Media and Technology Group Corp pays none. Which is the better fit depends on your goals.
| ABT | DJT | |
|---|---|---|
Market Cap | $166.94B | $2.25B |
Sector | Health | Media |
52-Week High | $136.62 | $19.86 |
52-Week Low | $82.57 | $7.06 |
Enterprise Value | $193.69B | $2.20B |
Dividend Yield | 2.63% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Abbott Laboratories (ABT) trades at $95.63, up 0.25% on the day, with a bullish technical signal from moving averages and strong analyst support. The stock shows solid fundamentals with a P/E of 26.79 and net income margin of 13.91%, though recent earnings have been mixed. Recent news highlights regulatory approvals for new medical devices, supporting growth prospects.
The outlook remains positive with a consensus price target of $122.55, implying significant upside. Key risks include competitive pressures and macroeconomic headwinds, but strong institutional backing and consistent dividend payments provide stability for long-term investors.
DJT trades at $8.66, up 1.41% today, with a bullish technical signal from moving averages despite neutral oscillators. Fundamentally, the company reported minimal revenue of $3.68M in 2025 with a massive net loss of -$712M, resulting in negative profit margins and ROE. Recent news highlights significant stock declines, with the company's market value dropping nearly 75% from its peak amid strategic shifts including a planned merger with TAE Technologies.
The outlook remains highly speculative with severe profitability challenges offset by potential catalysts from the TAE merger. Key risks include persistent losses, minimal revenue growth, and high volatility. Institutional sentiment is cautious given the extreme valuation metrics and operational uncertainties facing the social media platform.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abbott Laboratories
Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
Read more on ABT →About Trump Media and Technology Group Corp
Trump Media & Technology Group is a media firm rooted in social media and digital streaming. Its flagship product, Truth Social, provides a platform focused on free speech and open conversation.
Read more on DJT →
